Biocon Opinion UK's diabetes challenge could be helped by generic GLP-1s and biosimilars Shreehas TambeShajil KumarMay 23, 2026
News Zydus and Roche in legal battle over biosimilar amid rising breast cancer cases in India Longjam Dineshwori02 August 2024
News Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform pharmacy.biz Staff15 June 2023
News BGMA calls for VPAS exemption for branded generics and biosimilars pharmacy.biz Staff26 October 2022